Cell-based compositions and methods of their use to inhibit an adverse immune responsesuch as graft versus host disease or rejection of transplanted tissue in a transplantrecipient that is histocompatibility mismatched to the transplant donor aredisclosed. The compositions and methods utilize postpartum-derived cells,such as cells derived from the placenta or umbilicus.